#NonPrescription-Drugs

Sustainability challenge and related SDGs

Every one of us gets sick from time to time. It is estimated that about half of the world's population suffers from headaches once or more per year, while up to 4% of the population suffer from them more than 15 days per month.

While headaches or migraines can be very painful, other treatable conditions can be fatal. It is estimated that there are 1.7 billion cases of diarrhea in children each year. About 525,000 of these result in the death of children under the age of five. Both of these diseases can be treated with #NonPrescriptionDrugs. The same is true for several other diseases that plague humanity. While a healthy lifestyle is the best prevention against many diseases, sometimes #NonPrescriptionDrugs are necessary to achieve SDG 3 "Good Health and Well-Being".

Possible solutions and their contribution to achieving the SDGs

#NonPrescriptionDrugs are medicines that can be sold directly to end customers without a doctor's prescription. They are also referred to as over-the-counter pharmaceuticals. They treat a variety of illnesses and their symptoms, such as pain, coughs and colds, diarrhoea, constipation, acne, and many more.
This raditag covers everything related to #NonPrescriptionDrugs from manufacturing, packaging, distribution, trade, wholesale and retail of pharmaceuticals.

Primarily related SDG Targets:  3.1, 3.2, 3.3, 3.4, 3.5, 3.6, 3.8, 3.9, 3.b

Investment Rationale and Growth Potential

#NonPrescriptionDrugs are increasingly available for a wide range of diseases. This will significantly boost sales of over-the-counter drugs for years to come. The regular occurrence of flu and colds and other respiratory diseaes is driving demand for medicines. The market for all #NonPrescriptionDrugs is expected to grow by around 5% per year.